New model may help predict survival in breast cancer patients with brain lining spread
NCT ID NCT07386886
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 403 breast cancer patients whose cancer had spread to the lining of the brain and spinal cord. Researchers collected detailed medical information to understand what factors affect survival. They used this data to create a new scoring system that could help doctors predict how long patients might live and guide treatment decisions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a better way to predict outcomes for breast cancer patients with leptomeningeal metastasis, helping doctors tailor treatment.
- What could go wrong
- This is an observational study, not a treatment trial. The new model needs further testing in other groups before it can be widely used.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEPTOMENINGEAL METASTASIS IN BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.